Cargando…

Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists

Cardiovascular disease remains one of the most prominent global health problems and has been demonstrated to disproportionally affect certain communities. Despite an increasing collective effort to improve health inequalities, a multitude of disparities continue to affect cardiovascular outcomes. Am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khedagi, Apurva, Hoke, Cara, Kelsey, Michelle, Coviello, Andrea, Jones, W. Schuyler, Jackson, Larry R., Patel, Manesh R, McGarrah, Rob W., Pagidipati, Neha J, Shah, Nishant P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	State-of-the-Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006446/ https://www.ncbi.nlm.nih.gov/pubmed/36915710 http://dx.doi.org/10.1016/j.ajpc.2023.100477

Ejemplares similares

GLP-1 receptor agonists, SGLT-2 inhibitors, and obstructive sleep apnoea: can new allies face an old enemy?
por: Papaetis, Georgios S.
Publicado: (2023)

Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis
por: Packer, Milton
Publicado: (2022)

Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes
por: Packer, Milton, et al.
Publicado: (2023)

Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
por: Salah, Husam M., et al.
Publicado: (2021)

Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review
por: Lopaschuk, Gary D., et al.
Publicado: (2020)

Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection
por: Michos, Erin D., et al.
Publicado: (2023)

Personal strategies to minimise effects of air pollution on respiratory health: advice for providers, patients and the public
por: Carlsten, Christopher, et al.
Publicado: (2020)

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review
por: Wesley Milks, Michael, et al.
Publicado: (2021)

The neonatal intensive parenting unit: an introduction
por: Hall, S L, et al.
Publicado: (2017)

Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium
por: Kandzari, David E., et al.
Publicado: (2022)

A New Era in Cardiac Rehabilitation Delivery: Research Gaps, Questions, Strategies, and Priorities
por: Beatty, Alexis L., et al.
Publicado: (2023)

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk
por: Urban, Philip, et al.
Publicado: (2019)

Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review
por: Shapiro, Adam J., et al.
Publicado: (2015)

Sarcopenia and Cardiovascular Diseases
por: Damluji, Abdulla A., et al.
Publicado: (2023)

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients
por: Eichler, H‐G, et al.
Publicado: (2015)

SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain
por: Rolek, Bartosz, et al.
Publicado: (2023)

Emergent processes in cognitive-emotional interactions
por: Pessoa, Luiz
Publicado: (2010)

Bipolar disorder
por: Goodwin, Frederick K., et al.
Publicado: (1999)

Depression in late life
por: Barry, D. Lebowitz
Publicado: (1999)

The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosis
por: Davidson, Michael, et al.
Publicado: (2005)

Genetic bases for endophenotypes in psychiatric disorders
por: Berrettini, Wade H.
Publicado: (2005)

The pharmacological management of depression
por: Kupfer, David J.
Publicado: (2005)

Sleep and psychiatry
por: Abad, Vivien C., et al.
Publicado: (2005)

Various forms of depression
por: Benazzi, Franco
Publicado: (2006)

Chronobiology and mood disorders
por: Wirz-Justice, Anna
Publicado: (2003)

Concepts in human biological rhythms
por: Reinberg, Alain, et al.
Publicado: (2003)

Genetic variation and pharmacogenomics: concepts, facts, and challenges
por: Hoehe, Margret R., et al.
Publicado: (2004)

Structural plasticity of the adult brain: how animal models help us understand brain changes in depression and systemic disorders related to depression
por: McEwen, Bruce S.
Publicado: (2004)

Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder
por: Alexander, Garrett E.
Publicado: (2004)

Mild cognitive impairment: historical development and summary of research
por: Golomb, James, et al.
Publicado: (2004)

Expression profiling of drug response - from genes to pathways
por: Herwig, Ralf, et al.
Publicado: (2006)

Protective and damaging effects of stress mediators: central role of the brain
por: McEwen, Bruce S.
Publicado: (2006)

Depression and cardiovascular comorbidity
por: Glassman, Alexander H.
Publicado: (2007)

Psychosis in children: diagnosis and treatment
por: Courvoisie, Helen, et al.
Publicado: (2001)

Cerebral aging: integration of brain and behavioral models of cognitive function
por: Park, Denise C., et al.
Publicado: (2001)

A plausible model of schizophrenia must incorporate psychological and social, as well as neuro developmental, risk factors
por: Bramon, Elvira, et al.
Publicado: (2001)

Pathophysiology of depression and mechanisms of treatment
por: Brigitta, Bondy
Publicado: (2002)

Gonadal steroids, brain, and behavior: role of context
por: Rubinow, David R., et al.
Publicado: (2002)

The biology of fear- and anxiety-related behaviors
por: Steimer, Thierry
Publicado: (2002)

Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?
por: Ravona-Springer, Ramit, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_3re0ine8btg3s9obn1ojp6e8rh